Tomoko Ishibashi

1.7k total citations · 1 hit paper
40 papers, 1.4k citations indexed

About

Tomoko Ishibashi is a scholar working on Developmental Neuroscience, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Tomoko Ishibashi has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Developmental Neuroscience, 15 papers in Cellular and Molecular Neuroscience and 11 papers in Molecular Biology. Recurrent topics in Tomoko Ishibashi's work include Neurogenesis and neuroplasticity mechanisms (16 papers), Nerve injury and regeneration (8 papers) and Signaling Pathways in Disease (6 papers). Tomoko Ishibashi is often cited by papers focused on Neurogenesis and neuroplasticity mechanisms (16 papers), Nerve injury and regeneration (8 papers) and Signaling Pathways in Disease (6 papers). Tomoko Ishibashi collaborates with scholars based in Japan, United States and Romania. Tomoko Ishibashi's co-authors include R. Douglas Fields, Beth Stevens, Philip R. Lee, Colin L. Stewart, С. В. Козлов, Hiroko Baba, Kazuhiro Ikenaka, Yoshiaki Somekawa, Elior Peles and Koichi Honke and has published in prestigious journals such as Neuron, Journal of Neuroscience and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Tomoko Ishibashi

37 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Astrocytes Promote Myelination in Response to Electrical Impulses

2006 522 citations Tomoko Ishibashi, Beth Stevens et al. Neuron profile →

Peers

Countries citing papers authored by Tomoko Ishibashi

Since Specialization

Citations

This map shows the geographic impact of Tomoko Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Ishibashi more than expected).

Fields of papers citing papers by Tomoko Ishibashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Ishibashi. The network helps show where Tomoko Ishibashi may publish in the future.

Co-authorship network of co-authors of Tomoko Ishibashi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Ishibashi. A scholar is included among the top collaborators of Tomoko Ishibashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Ishibashi. Tomoko Ishibashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Degree of twist in the Achilles tendon interacts with its length and thickness in affecting local strain magnitude: a finite element analysis 2024 ·Frontiers in Bioengineering and Biotechnology ·(unknown), (unknown), Tomoko Ishibashi, Shinichiro Yamada, Toshiaki Oda	0
2	Intravenous immunoglobulin preparations attenuate lysolecithin-induced peripheral demyelination in mice and comprise anti-large myelin protein zero antibody 2023 ·Proceedings of the Japan Academy Series B ·(unknown), Akiko Hayashi, (unknown), (unknown), (unknown), (unknown), Tomoko Ishibashi, Hiroaki Takimoto, Yoshihide Yamaguchi, Hirokazu Ohtaki, Hiroko Baba	1
3	Paranodal Axoglial Junctions, an Essential Component in Axonal Homeostasis 2022 ·Frontiers in Cell and Developmental Biology ·Tomoko Ishibashi, Hiroko Baba	7
4	Effects of propofol versus sevoflurane on cerebral circulation time in patients undergoing coiling for cerebral artery aneurysm: a prospective randomized crossover study 2019 ·Journal of Clinical Monitoring and Computing ·Tomoko Ishibashi, Satoshi Toyama, Kazunori Miki, (unknown), Yoshikazu Yoshino, Satoru Ishibashi, Makoto Tomita, Shigeru Nemoto	6
5	A case of unexpected impaired oxygenation due to intraoperative pneumothorax: an adverse event associated with respiratory management with spontaneous respiration in a patient with esophagobronchial fistulae 2017 ·JA Clinical Reports ·Seiji Ishikawa, (unknown), Tomoko Ishibashi, Koshi Makita	0
6	Expression of Unconventional Myosin VI in Oligodendrocytes 2017 ·Neurochemical Research ·Reiji Yamazaki, Tomoko Ishibashi, Hiroko Baba, Yoshihide Yamaguchi	5
7	Microglial phospholipase D4 deficiency influences myelination during brain development 2016 ·Proceedings of the Japan Academy Series B ·Terumasa Chiba, (unknown), Yoshihide Yamaguchi, Tomoko Ishibashi, Akiko Hayashi, Kenji F. Tanaka, Maya Yamazaki, Kenji Sakimura, Hiroko Baba	6
8	Reversible cerebral vasoconstriction syndrome with limb myoclonus following intravenous administration of methylergometrine 2011 ·Journal of Anesthesia ·Tomoko Ishibashi, Satoru Ishibashi, Tokujiro Uchida, Koichi Nakazawa, Koshi Makita	13
9	Elevated Maternal Serum Folate in the Third Trimester and Reduced Fetal Growth: A Longitudinal Study 2011 ·Journal of Nutritional Science and Vitaminology ·Hidemi Takimoto, Fumi Hayashi, Kaoru Kusama, Noriko Kato, Nobuo Yoshiike, (unknown), Tomoko Ishibashi, Naoyuki Miyasaka, Toshiro Kubota	24
10	Clinical Development and Review Times for New Drugs in Japan: Associated Factors 2010 ·Clinical Pharmacology & Therapeutics ·Tomoko Ishibashi, Kazuto Yasuda, Makiko Kusama, Yuichi Sugiyama, Shunsuke Ono	17
11	Mice with Altered Myelin Proteolipid Protein Gene Expression Display Cognitive Deficits Accompanied by Abnormal Neuron-Glia Interactions and Decreased Conduction Velocities 2009 ·Journal of Neuroscience ·Hajime Tanaka, Jianmei Ma, Kenji F. Tanaka, Keizo Takao, Masayuki Komada, Koichi Tanda, Ayaka Suzuki, Tomoko Ishibashi, Hiroko Baba, Tadashi Isa, Ryuichi Shigemoto, Katsuhiko Ono, Tsuyoshi Miyakawa, Kazuhiro Ikenaka	65
12	Leukemia inhibitory factor regulates the timing of oligodendrocyte development and myelination in the postnatal optic nerve 2009 ·Journal of Neuroscience Research ·Tomoko Ishibashi, Philip R. Lee, Hiroko Baba, R. Douglas Fields	48
13	Possible Involvement of Altered Arginase Activity, Arginase Type I and Type II Expressions, and Nitric Oxide Production in Occurrence of Intimal Hyperplasia in Premenopausal Human Uterine Arteries 2008 ·Journal of Pharmacological Sciences ·(unknown), Renzo Y. Loyaga‐Rendon, Satoshi Obayashi, Tomoko Ishibashi, Toshiro Kubota, Masatoshi Imamura, Hiroshi Azuma	20
14	Astrocytes Promote Myelination in Response to Electrical Impulses breakdown → 2006 ·Neuron ·Tomoko Ishibashi, (unknown), Beth Stevens, Philip R. Lee, С. В. Козлов, Colin L. Stewart, R. Douglas Fields	522
15	Tetraspanin Protein CD9 Is a Novel Paranodal Component Regulating Paranodal Junctional Formation 2004 ·Journal of Neuroscience ·Tomoko Ishibashi, Lei Ding, Kazuhiro Ikenaka, Yoshiro Inoue, Kenji Miyado, Eisuke Mekada, Hiroko Baba	54
16	Adenosine: an activity-dependent axonal signal regulating MAP kinase and proliferation in developing Schwann cells 2004 ·PubMed ·Beth Stevens, Tomoko Ishibashi, Jiang‐Fan Chen, R. Douglas Fields	56
17	Initiation of Sodium Channel Clustering at the Node of Ranvier in the Mouse Optic Nerve 2003 ·Neurochemical Research ·Tomoko Ishibashi, Kazuhiro Ikenaka, Takeshi Shimizu, T. Kagawa, Hiroko Baba	12
18	Use of Vitamin K₂(Menatetrenone) and 1,25-dihydroxyvitamin D₃in the Prevention of Bone Loss Induced by Leuprolide¹ 1999 ·The Journal of Clinical Endocrinology & Metabolism ·Yoshiaki Somekawa, (unknown), (unknown), Tomoko Ishibashi	35
19	Completion of myelin compaction, but not the attachment of oligodendroglial processes triggers K channel clustering 1999 ·Journal of Neuroscience Research ·(unknown), (unknown), Tomoko Ishibashi, Yoshiro Inoue, Kensuke Nakahira, Kazuhiro Ikenaka	1
20	Classifying the economically productive population as persons aged 20-69. 1998 ·PubMed ·Tomoko Ishibashi	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact